Novartis opens radioligand therapy manufacturing facility in California
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
The expanded mbDNA portfolio delivers enhanced stability, reduced immunogenicity, and broad compatibility with gene insertion and expression technologies
This latest commitment brings the British pharmaceutical company’s total investment at the site to $886 million
Cupid has been allocated approximately 23.4 million units of female condoms per year
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
Kulzer has consolidated the production of its core product, artificial teeth, at its facility in Germany
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
The FDA’s review also revealed delays in Philips’ internal investigations, with 54 inquiries failing to meet targeted completion dates—23 of which were delayed by more than 100 days
Company plans to create 100 manufacturing jobs and up to 1,000 construction jobs
Subscribe To Our Newsletter & Stay Updated